Research and Clinical Trials

The new executive director of Mayo Clinic Cancer Programs and director of Mayo Clinic Cancer Center, Dr. Cheryl Willman, shares her thoughts on how to reach all those in need of cancer care.

A recent study provides support for Mayo Clinic's use of positron emission tomography (PET) to guide pancreatic cancer treatment decisions.

Adding mRNA therapy improves the response to cancer immunotherapy in people who weren't responding to the treatment, Mayo Clinic research shows.

Hematologist-oncologist Dr. Allison Rosenthal discusses plans to launch a formal program for adolescents and young adults with cancer at Mayo Clinic in 2022.

Mayo Clinic is sequencing the exomes of tens of thousands of people from diverse backgrounds to investigate large-scale patterns of distinctive mutations that fuel disease.

The American Society of Hematology (ASH) recognized Mayo Clinic hematologist Stephen Ansell, M.D., with the highly distinguished Ernest Beutler Lecture and Prize in recognition of his significant contributions to the field of lymphoma research.

When it comes to developing a care plan for older adults with glioblastoma, it's important to weigh the benefits of treatment against side effects that might reduce quality of life.

A new Mayo Clinic study finds 1 in 6 people with pancreatic cancer harbor inherited genetic mutations.

Research by Antonio Forte, M.D., Ph.D., a Mayo Clinic plastic surgeon, seeks to better pinpoint who is most likely to benefit from surgery aimed at regenerating a faulty lymphatic system.

Mayo Clinic researchers have found that a new, shorter treatment for patients with HPV-associated oropharynx cancer leads to excellent disease control and fewer side effects, compared to standard treatment.